Robert W. Doms
#123,389
Most Influential Person Now
Robert W. Doms's AcademicInfluence.com Rankings
Robert W. Domsbiology Degrees
Biology
#7624
World Rank
#10574
Historical Rank
Microbiology
#374
World Rank
#426
Historical Rank
Immunology
#415
World Rank
#431
Historical Rank
Download Badge
Biology
Robert W. Doms's Degrees
- PhD Microbiology and Immunology University of Pennsylvania
- Bachelors Biology University of California, San Diego
Similar Degrees You Can Earn
Why Is Robert W. Doms Influential?
(Suggest an Edit or Addition)Robert W. Doms's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene (1996) (2991)
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors (1996) (1991)
- A new classification for HIV-1 (1998) (899)
- HIV vaccine design and the neutralizing antibody problem (2004) (835)
- CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 (1996) (712)
- Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. (1999) (601)
- Diversity of receptors binding HIV on dendritic cell subsets (2002) (561)
- Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum (1989) (540)
- HIV: cell binding and entry. (2012) (527)
- Genetic acceleration of AIDS progression by a promoter variant of CCR5. (1998) (483)
- Folding and assembly of viral membrane proteins. (1993) (473)
- Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro (2002) (459)
- Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells (1997) (451)
- Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics (2002) (439)
- Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR (2003) (426)
- Phenotypic properties of transmitted founder HIV-1 (2013) (389)
- Human immunodeficiency virus type 2. (2002) (386)
- A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains (1996) (384)
- Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. (1990) (378)
- Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme (2000) (370)
- Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* (1999) (370)
- Assembly of influenza hemagglutinin trimers and its role in intracellular transport (1986) (361)
- DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. (2003) (359)
- Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses (1997) (357)
- Regulation of protein export from the endoplasmic reticulum. (1988) (357)
- Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein (1991) (356)
- A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor (1997) (329)
- Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. (1985) (324)
- Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity (1996) (324)
- Protein Kinase C-dependent α-Secretase Competes with β-Secretase for Cleavage of Amyloid-β Precursor Protein in the Trans-Golgi Network* (2000) (321)
- DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans (2001) (318)
- Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus (1986) (314)
- West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection (2006) (306)
- Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks (1993) (302)
- Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture (1998) (297)
- Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. (1999) (296)
- The entry of entry inhibitors: A fusion of science and medicine (2003) (294)
- The plasma membrane as a combat zone in the HIV battlefield. (2000) (286)
- Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. (1997) (286)
- Microglia Express CCR5, CXCR4, and CCR3, but of These, CCR5 Is the Principal Coreceptor for Human Immunodeficiency Virus Type 1 Dementia Isolates (1999) (283)
- Expression of DC-SIGN by Dendritic Cells of Intestinal and Genital Mucosae in Humans and Rhesus Macaques (2002) (282)
- CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. (1999) (278)
- CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. (1997) (277)
- Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers (1987) (266)
- ChemR23, a putative chemoattractant receptor, is expressed in monocyte‐derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV‐1 strains (1998) (259)
- Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR (2003) (255)
- Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1 (1997) (244)
- Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities (1994) (238)
- Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo (2005) (237)
- Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions (1999) (236)
- Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. (1997) (236)
- DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency Virus (2001) (227)
- Protein-mediated membrane fusion. (1989) (226)
- Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. (1997) (223)
- Entry inhibitors in the treatment of HIV-1 infection. (2010) (221)
- Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. (2000) (221)
- An Orphan Seven-Transmembrane Domain Receptor Expressed Widely in the Brain Functions as a Coreceptor for Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus (1998) (218)
- Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. (1996) (216)
- N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity (2005) (208)
- cis Expression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor (2001) (207)
- Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation (1997) (207)
- Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons (2000) (207)
- Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors (2007) (204)
- Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. (2000) (202)
- Molecular mechanisms of HIV entry. (2012) (199)
- Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein (1988) (196)
- A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. (2006) (193)
- Intracellular APP Processing and Aβ Production in Alzheimer Disease (1999) (183)
- The CC Chemokine I-309 Inhibits CCR8-dependent Infection by Diverse HIV-1 Strains* (1998) (181)
- Antigenically Distinct Conformations of CXCR4 (2001) (180)
- Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane (1990) (177)
- Truncation of the Cytoplasmic Domain Induces Exposure of Conserved Regions in the Ectodomain of Human Immunodeficiency Virus Type 1 Envelope Protein (2002) (176)
- Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques (2016) (174)
- Influence of the CCR2-V64I Polymorphism on Human Immunodeficiency Virus Type 1 Coreceptor Activity and on Chemokine Receptor Function of CCR2b, CCR3, CCR5, and CXCR4 (1998) (174)
- HIV-1 Membrane Fusion (2000) (171)
- Enfuvirtide Resistance Mutations: Impact on Human Immunodeficiency Virus Envelope Function, Entry Inhibitor Sensitivity, and Virus Neutralization (2005) (169)
- The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle* (2003) (168)
- Identification of Determinants on a Dualtropic Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Confer Usage of CXCR4 (1998) (168)
- β-Secretase Processing in the Trans-Golgi Network Preferentially Generates Truncated Amyloid Species That Accumulate in Alzheimer's Disease Brain* (2002) (166)
- HIV Transmission (2004) (165)
- Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein. (1990) (164)
- HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. (2000) (161)
- Multiple Charged and Aromatic Residues in CCR5 Amino-terminal Domain Are Involved in High Affinity Binding of Both Chemokines and HIV-1 Env Protein* (1999) (160)
- Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection (2003) (157)
- Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1 (2000) (156)
- Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. (1998) (156)
- Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7 (2012) (154)
- Placental expression of DC‐SIGN may mediate intrauterine vertical transmission of HIV (2001) (152)
- Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope Protein (2001) (148)
- Retroviral mRNA nuclear export elements regulate protein function and virion assembly (2004) (146)
- Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins (2011) (146)
- Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment (1990) (144)
- Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases (2011) (144)
- Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways* (2001) (144)
- Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. (2014) (139)
- Determinants of CD4 Independence for a Human Immunodeficiency Virus Type 1 Variant Map outside Regions Required for Coreceptor Specificity (1999) (138)
- Chemokine Receptor Utilization by Human Immunodeficiency Virus Type 1 Isolates That Replicate in Microglia (1998) (136)
- BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo (2005) (135)
- CD4 Independence of Simian Immunodeficiency Virus Envs Is Associated with Macrophage Tropism, Neutralization Sensitivity, and Attenuated Pathogenicity (2002) (135)
- A Sound Rationale Needed for Phase III HIV-1 Vaccine Trials (2004) (133)
- Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. (1994) (132)
- Characterization of neutralizing antibodies to West Nile virus. (2005) (130)
- Quaternary structure of influenza virus hemagglutinin after acid treatment (1986) (129)
- Novel β-Secretase Cleavage of β-Amyloid Precursor Protein in the Endoplasmic Reticulum/Intermediate Compartment of NT2N Cells (1997) (128)
- Impact of Mutations in the Coreceptor Binding Site on Human Immunodeficiency Virus Type 1 Fusion, Infection, and Entry Inhibitor Sensitivity (2004) (127)
- Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression. (2002) (126)
- Extracellular Cysteines of CCR5 Are Required for Chemokine Binding, but Dispensable for HIV-1 Coreceptor Activity* (1999) (125)
- Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins (2005) (124)
- HIV-1 entry and its inhibition. (2003) (124)
- Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65 (1994) (123)
- A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5 (2010) (119)
- Use of a gp120 Binding Assay To Dissect the Requirements and Kinetics of Human Immunodeficiency Virus Fusion Events (1999) (116)
- Quantitative Expression and Virus Transmission Analysis of DC-SIGN on Monocyte-Derived Dendritic Cells (2002) (115)
- Multiple nonfunctional alleles of CCR5 are frequent in various human populations. (2000) (115)
- Safe use of the CXCR4 inhibitor ALX40-4C in humans. (2001) (114)
- HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. (1998) (112)
- HIV-1 envelope determinants for cell tropism and chemokine receptor use. (1999) (112)
- Comparing Antigenicity and Immunogenicity of Engineered gp120 (2005) (111)
- DC-SIGN and DC-SIGNR: helping hands for HIV. (2001) (111)
- HIV-1 coreceptors and their inhibitors. (2006) (109)
- A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors. (2000) (109)
- Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein (1997) (109)
- The Location of Asparagine-linked Glycans on West Nile Virions Controls Their Interactions with CD209 (Dendritic Cell-specific ICAM-3 Grabbing Nonintegrin)* (2006) (102)
- Presenilins are not required for Aβ42 production in the early secretory pathway (2002) (102)
- An infectious West Nile virus that expresses a GFP reporter gene. (2005) (99)
- Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers (1988) (98)
- Intracellular transport of soluble and membrane‐bound glycoproteins: folding, assembly and secretion of anchor‐free influenza hemagglutinin. (1990) (97)
- Modulation of Env Content in Virions of Simian Immunodeficiency Virus: Correlation with Cell Surface Expression and Virion Infectivity (2004) (97)
- Variant influenza virus hemagglutinin that induces fusion at elevated pH (1986) (97)
- Functional Dissection of CCR5 Coreceptor Function through the Use of CD4-Independent Simian Immunodeficiency Virus Strains (1999) (97)
- Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry. (2013) (96)
- Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. (2000) (96)
- The Chemokine Stromal Cell-Derived Factor-1 Promotes the Survival of Embryonic Retinal Ganglion Cells (2003) (94)
- A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection (2015) (94)
- Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry. (1997) (93)
- The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. (2001) (91)
- V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies (2007) (90)
- Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection. (1999) (88)
- A Replication-Competent, Neutralization-Sensitive Variant of Simian Immunodeficiency Virus Lacking 100 Amino Acids of Envelope (2002) (88)
- Membrane Topology of γ-Secretase Component PEN-2* (2003) (88)
- Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5 (2012) (85)
- Functional and Antigenic Characterization of Human, Rhesus Macaque, Pigtailed Macaque, and Murine DC-SIGN (2001) (82)
- Membrane Topology and Nicastrin-enhanced Endoproteolysis of APH-1, a Component of the γ-Secretase Complex* (2004) (80)
- Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein (1996) (79)
- Identification of a Novel C-Terminal Cleavage of Crimean-Congo Hemorrhagic Fever Virus PreGN That Leads to Generation of an NSM Protein (2007) (79)
- Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1) (1997) (79)
- CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. (1997) (78)
- Secretion and Intracellular Generation of Truncated Aβ in β-Site Amyloid-β Precursor Protein-cleaving Enzyme Expressing Human Neurons* (2003) (77)
- Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques. (1999) (76)
- The Major Cellular Sterol Regulatory Pathway Is Required for Andes Virus Infection (2014) (75)
- Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility ofHuman Immunodeficiency Virus Type 1 to Other Classes of Entry Inhibitors (2007) (75)
- The Transmembrane Domain Region of Nicastrin Mediates Direct Interactions with APH-1 and the γ-Secretase Complex* (2003) (75)
- Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes. (1999) (73)
- DC-SIGN Interactions with Human Immunodeficiency Virus: Virus Binding and Transfer Are Dissociable Functions (2001) (72)
- Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. (2002) (72)
- A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP. (2000) (71)
- Chemokines and coreceptors in HIV/SIV-host interactions. (1998) (67)
- Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide (1994) (67)
- Characterization and Epitope Mapping of Neutralizing Monoclonal Antibodies Produced by Immunization with Oligomeric Simian Immunodeficiency Virus Envelope Protein (2000) (67)
- Chemokine receptors and HIV entry. (2001) (67)
- Prospects of HIV‐1 entry inhibitors as novel therapeutics (2004) (66)
- HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells (2010) (66)
- HIV-1 Membrane Fusion: Targets of Opportunity (2000) (65)
- Structure-function studies of the HIV-1 coreceptors. (1998) (65)
- HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry. (2010) (64)
- An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies (2008) (63)
- CD4-independent utilization of the CXCR4 chemokine receptor by HIV-1 and HIV-2. (1998) (62)
- Intracellular APP processing and A beta production in Alzheimer disease. (1999) (60)
- HR-2 Mutations in Human Immunodeficiency Virus Type 1 gp41 Restore Fusion Kinetics Delayed by HR-1 Mutations That Cause Clinical Resistance to Enfuvirtide (2009) (58)
- Novel Approaches to Inhibit HIV Entry (2012) (58)
- Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism (2011) (57)
- Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain (1990) (56)
- Qualitative T-Helper Responses to Multiple Viral Antigens Correlate with Vaccine-Induced Immunity to Simian/Human Immunodeficiency Virus Infection (2004) (56)
- Development and characterization of a Rift Valley fever virus cell–cell fusion assay using alphavirus replicon vectors (2006) (56)
- The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? (2002) (56)
- Differential Effects of the Swedish Mutant Amyloid Precursor Protein on β-Amyloid Accumulation and Secretion in Neurons and Nonneuronal Cells* (1997) (55)
- Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus. (2005) (55)
- Chemokine and orphan receptors in HIV-2 and SIV tropism and pathogenesis. (1999) (55)
- Rift Valley Fever Virus Infection of Human Cells and Insect Hosts Is Promoted by Protein Kinase C Epsilon (2010) (55)
- Identification of gp120 Binding Sites on CXCR4 by Using CD4-Independent Human Immunodeficiency Virus Type 2 Env Proteins (2003) (52)
- Enhanced Exposure of the CD4-Binding Site to Neutralizing Antibodies by Structural Design of a Membrane-Anchored Human Immunodeficiency Virus Type 1 gp120 Domain (2009) (48)
- An Intricate Web: Chemokine Receptors, HIV‐1 and Hematopoiesis (1998) (47)
- Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140. (2008) (47)
- Quantitative Phosphoproteomics of CXCL12 (SDF-1) Signaling (2011) (45)
- Expression and coreceptor function of APJ for primate immunodeficiency viruses. (2000) (45)
- HIV and SIV gp120 binding does not predict coreceptor function. (1999) (44)
- The influenza hemagglutinin precursor as an acid‐sensitive probe of the biosynthetic pathway. (1987) (44)
- Leukotriene Binding, Signaling, and Analysis of HIV Coreceptor Function in Mouse and Human Leukotriene B4Receptor-transfected Cells* (1999) (43)
- Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities. (2009) (42)
- Secretion and intracellular generation of truncated Abeta in beta-site amyloid-beta precursor protein-cleaving enzyme expressing human neurons. (2003) (42)
- Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation. (2004) (42)
- Yeast-Elicited Cross-Reactive Antibodies to HIV Env Glycans Efficiently Neutralize Virions Expressing Exclusively High-Mannose N-Linked Glycans (2010) (41)
- Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque STRL33 for Efficient Entry (2000) (41)
- AIDS models: Microbicides could learn from vaccines (2002) (40)
- Quantification of CD 4 , CCR 5 , and CXCR 4 levels on lymphocyte subsets , dendritic cells , and differentially conditioned monocyte-derived macrophages (1999) (39)
- Unique Pattern of Convergent Envelope Evolution in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques: Association with CD4-Independent Usage of CCR5 (2003) (38)
- Distinct presenilin‐dependent and presenilin‐independent γ‐secretases are responsible for total cellular Aβ production (2003) (36)
- Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists (2007) (36)
- Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers (1992) (36)
- The neutralizing antibody response against West Nile virus in naturally infected horses. (2007) (36)
- Endoproteolysis of β-Secretase (β-Site Amyloid Precursor Protein-cleaving Enzyme) within Its Catalytic Domain (2003) (36)
- A Yeast Glycoprotein Shows High-Affinity Binding to the Broadly Neutralizing Human Immunodeficiency Virus Antibody 2G12 and Inhibits gp120 Interactions with 2G12 and DC-SIGN (2009) (36)
- Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Potent Inhibitor of R5-Tropic Human Immunodeficiency Virus Type 1 Strains in Primary T Cells and Macrophages (2002) (36)
- Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion (2006) (34)
- HIV-1 entry inhibitors: new targets, novel therapies. (2003) (34)
- Determinants within gp120 and gp41 contribute to CD4 independence of SIV Envs. (2004) (33)
- Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease. (2000) (33)
- Amino Acid 324 in the Simian Immunodeficiency Virus SIVmac V3 Loop Can Confer CD4 Independence and Modulate the Interaction with CCR5 and Alternative Coreceptors (2004) (32)
- Functional impact of HIV coreceptor-binding site mutations. (2006) (31)
- Adaptive Mutations in a Human Immunodeficiency Virus Type 1 Envelope Protein with a Truncated V3 Loop Restore Function by Improving Interactions with CD4 (2009) (31)
- Induction of Antibodies in Guinea Pigs and Rhesus Monkeys against the Human Immunodeficiency Virus Type 1 Envelope: Neutralization of Nonpathogenic and Pathogenic Primary Isolate Simian/Human Immunodeficiency Virus Strains (2000) (31)
- β-Chemokine MDC and HIV-1 Infection (1998) (30)
- N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus. (2008) (28)
- Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies. (2012) (27)
- Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains. (2010) (27)
- CD4-Independent Use of Rhesus CCR5 by Human Immunodeficiency Virus Type 2 Implicates an Electrostatic Interaction between the CCR5 N Terminus and the gp120 C4 Domain (2001) (26)
- Stable secretion of a soluble, oligomeric form of rabies virus glycoprotein: influence of N-glycan processing on secretion. (1995) (26)
- Exploitation of the Vbeta8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector. (1996) (26)
- Kruppel-like Factor 2 Modulates CCR5 Expression and Susceptibility to HIV-1 Infection (2012) (26)
- Enhanced Exposure of the CD 4-Binding Site to Neutralizing Antibodies by Structural Design of a Membrane-Anchored Human Immunodeficiency Virus Type 1 gp 120 Domain (2009) (26)
- Novel b-Secretase Cleavage of b-Amyloid Precursor Protein in the Endoplasmic Reticulum / Intermediate Compartment of NT 2 N Cells (1997) (26)
- Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques. (2003) (25)
- Neurotoxic Traffic: Uncovering the Mechanics of Amyloid Production in Alzheimer's Disease (2001) (25)
- Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8 (2006) (25)
- 12 – Studies on the Mechanism of Membrane Fusion (1973) (25)
- N-glycosylation of human nicastrin is required for interaction with the lectins from the secretory pathway calnexin and ERGIC-53. (2006) (25)
- Structure and Function of CC-Chemokine Receptor 5 Homologues Derived from Representative Primate Species and Subspecies of the Taxonomic Suborders Prosimii and Anthropoidea (2003) (24)
- The bulk-flow hypothesis: not quite the end. (1995) (23)
- Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100 (2008) (23)
- Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin. (2007) (23)
- Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulation. (2003) (22)
- Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency. (2003) (21)
- Oligomerization and protein transport. (1990) (21)
- Chemokine receptors as HIV coreceptors: implications and interactions. (1998) (21)
- AIDS Vaccine Development (1998) (20)
- Unwelcome guests with master keys: how HIV enters cells and how it can be stopped. (2004) (20)
- Evaluation of current approaches to inhibit HIV entry. (2002) (19)
- Influence of the CCR 2V 64 I Polymorphism on Human Immunodeficiency Virus Type 1 Coreceptor Activity and on Chemokine Receptor Function of CCR 2 b , CCR 3 , CCR 5 , and CXCR 4 (1998) (19)
- Closing in on the amyloid cascade (2000) (19)
- Protein conformational changes in virus-cell fusion. (1993) (18)
- Expression of foreign proteins in a human neuronal system. (1994) (18)
- Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment. (2016) (18)
- Differential effects of the swedish mutant amyloid precursor protein on beta-amyloid accumulation and secretion in neurons and nonneuronal cells. (1998) (18)
- A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes (2010) (17)
- The assembly of the HIV-1 env glycoprotein into dimers and tetramers. (1991) (17)
- Properties of a Viral Fusion Protein (1988) (15)
- Opportunities and challenges in targeting HIV entry. (2002) (15)
- A Cell-Cell Fusion Assay to Monitor HIV-1 Env Interactions with Chemokine Receptors. (1999) (15)
- What Came First—the Virus or the Egg? (2017) (14)
- Gene Therapy Targeting HIV Entry (2014) (14)
- The impact of chemokine receptor conformational heterogeneity on HIV infection. (2001) (14)
- Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans. (2015) (14)
- Embedding persuasive design for self-health management systems in Dutch healthcare informatics education: Application of a theory-based method (2018) (11)
- Distinct presenilin-dependent and presenilin-independent gamma-secretases are responsible for total cellular Abeta production. (2003) (11)
- DNA vaccine protection against challenge with simian/human immunodeficiency virus 89.6 in rhesus macaques. (2000) (11)
- HIV Transmission : Closing All the Doors (2004) (10)
- Chapter 3 Basic Concepts A Step-by-Step Guide to Viral Infection (2016) (9)
- Vaccinia virus serves as an efficient vector for expressing heterologous proteins in human NTera 2 neurons (1996) (9)
- Viral entry denied. (2004) (8)
- Inef fi cient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR 5 complex at low cell surface CCR 5 densities (2009) (7)
- HIV-1 gp 120 and chemokines activate ion channels in primary macrophages through CCR 5 and CXCR 4 stimulation (2000) (7)
- Dissecting the neutralizing antibody specificities of broadly neutralizing sera from 1 HIV-1 infected donors 2 * (2007) (7)
- Identification and Characterization of a Potent , Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR 8 (2005) (6)
- Making Bunyaviruses Talk: Interrogation Tactics to Identify Host Factors Required for Infection (2016) (5)
- Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque STRL 33 for Efficient Entry (2000) (5)
- HIV entry: are all receptors created equal? (2002) (5)
- Fusion mediated by the HIV-1 envelope protein. (2000) (5)
- Quantifying Aβ(1-40) and Aβ (1-42) Using Sandwich-ELISA. (2000) (5)
- A Plea for Justice for Jailed Medical Workers (2006) (5)
- Prime, Boost, and Broaden (2010) (4)
- CHAPTER 33 – The Role of Chemokine Receptors in HIV Infection of Host Cells (2003) (4)
- A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo. (2007) (3)
- Quantification of HIV/SIV Coreceptor Expression (2001) (3)
- Comparative Evaluation of Choose Your Own Adventure and Traditional Linear Case Formats in Radiology Small Group Teaching. (2022) (2)
- HIV: much at stake with kidneys? (2000) (2)
- Interaction of human immunodeficiency virus type 1 envelope protein with liposomes containing galactosylceramide (1996) (2)
- Penetration of Influenza Virus Into Host Cells (1989) (2)
- Basic Concepts (2016) (1)
- Folding, Interaction withGRP78-BiP, Assembly, andTransport of theHumanImmunodeficiency VirusType1 Envelope Protein (1991) (1)
- Antibodies against Man α 1,2-Man α 1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains (2010) (1)
- Dual roles for the cytoplasmic domain of the VSV G protein: Protein transport and virus assembly (1988) (1)
- Fusing HIV and Chemokine Receptors (2011) (1)
- BIOSYNTHESIS OF APP AND Aβ: MULTIPLE PATHWAYS FOR THE GENERATION OF INTRACELLULAR Aβ (1998) (1)
- Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility of Human Immunodeficiency Virus Type 1 to Other Classes of Entry Inhibitors (cid:1) (2007) (1)
- HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4 (cid:1) T Cells (cid:1) (2010) (1)
- HIV-1 Coreceptors and Viral Tropism (1999) (0)
- Intracellular A-beta in neuronal and non-neuronal cells (2000) (0)
- Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors (cid:1) (2007) (0)
- Application of a theary-based method in educational programs for designing persuasive eHealth (2018) (0)
- P4-282 Association and localization of nicastrin influences the activity of the G-secretase complex (2004) (0)
- vaccinia virus with the cell membrane. Fusion of intra- and extracellular forms of (2013) (0)
- C106 Distinguishing Features of Transmitted/Founder HIV-1 (2013) (0)
- populations Multiple nonfunctional alleles of CCR5 are frequent in various human (2013) (0)
- InfectionExpression and Susceptibility to HIV-1 Kruppel-like Factor 2 Modulates CCR5 (2012) (0)
- Introduction to entry inhibitors in the management of HIV infection (2007) (0)
- CXCR 4 Envelope Glycoprotein That Confer Usage of Human Immunodeficiency Virus Type 1 Identification of Determinants on a Dualtropic (1998) (0)
- Human factors in designing persuasive eHealth to support self-management (2018) (0)
- Characterization ofHumanImmunodeficiency VirusType1 gpl20Binding toLiposomes Containing Galactosylceramide (1994) (0)
- Infection Expression and Susceptibility to HIV-1 Kruppel-like Factor 2 Modulates CCR 5 (2012) (0)
- Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100 (cid:1) (2008) (0)
- Identification of a Novel C-Terminal Cleavage of Crimean-Congo Hemorrhagic Fever Virus PreG N That Leads to Generation of an NS M Protein (cid:1) (2007) (0)
- Application of a theory-based method in educational programs for designing persuasive eHealth : A Dutch experience (2018) (0)
- RECEPTOR DOMAINS INVOLVED IN THE INTERACTION WITH CHEMOKINES AND HIV (1999) (0)
- Alzheimer's disease: Targeting of Nicastrin to sub-cellular compartments and its influence on G-secretase complex activity (2005) (0)
- A New Generation of Antiviral Therapeutics Designed to Prevent the Use of Chemokine Receptors for Entry by HIV-1 (2002) (0)
- BACE overexpression alters the subcellular processing of APP and inhibits A (cid:1) deposition in vivo (2005) (0)
- Domotica in de zorg; hype of zinvol (2015) (0)
- efficient activation of intracellular signaling pathways (2001) (0)
- Eliciting broadly neutralizing antibodies to human immunodeficiency virus could bring closer the goal of a successful AIDS vaccine. Here the International AIDS Vaccine Initiative Neutralizing Antibody Consortium discusses current approaches to overcome the problems faced. (2004) (0)
- [Psychosomatic aspects in functional disorders of the temporomandibular joint]. (1969) (0)
- Table of Contents (1990) (0)
- Title : 1 A haploid genetic screen identifies heparan sulfate proteoglycans supporting Rift Valley fever 2 virus infection 3 Running title : 4 Haploid screen identifies RVFV entry factors 5 Authors : 6 (2015) (0)
- patient-derived and prototype isolates resulting immunodeficiency virus : resistance to macrophage-tropic strains of human macrophages and lymphocytes by Role of CCR 5 in infection of primary (1997) (0)
- Drug-Bound CCR 5 and Extracellular Loop Domains of Antagonists Depends on both N-Terminal Cross-Resistance to Other CCR 5 A Maraviroc-Resistant HIV-1 with Narrow (2010) (0)
- P4-319 Assembly, trafficking, and activity of the gamma-secretase complex (2004) (0)
- KLF 2 Modulates CCR 5 Expression and Susceptibility to HIV-1 Infection 1 (2012) (0)
- Structure-function relationships of CCR5 as a chemokine receptor and HIV co-receptor (1998) (0)
- Viral Membrane Proteins as Tools to Study Protein Folding, Assembly, and Transport (1995) (0)
- 176 Exploring the Potential of CCR5 and CXCR4 Modified CD4 T Cells to Target the HIV-1 Reservoir (2011) (0)
- J. Virol.-2011-Jiang-10669-81 (2012) (0)
- Hbo‐Master Advanced Health (2014) (0)
- Influenza Virus Hemagglutinin and Membrane Fusion (2019) (0)
- Functional characterization of novel G protein-coupled receptors involved in nociception and HIV-1 infection (1997) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert W. Doms?
Robert W. Doms is affiliated with the following schools:
